<DOC>
	<DOCNO>NCT02877927</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy omadacycline compare linezolid treatment adult acute bacterial skin skin structure infection .</brief_summary>
	<brief_title>Oral Omadacycline v . Oral Linezolid Treatment ABSSSI</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Patients , age 18 year old sign inform consent Has qualifying skin skin structure infection Female patient must pregnant time enrollment Must agree reliable method birth control study 30 day follow last dose study drug Infections outcome strongly influence factor protocoldefined treatment procedure , require antibacterial treatment great 14 day Evidence significant immunological disease Severe renal disease requirement dialysis Evidence septic shock Has history hypersensitivity allergic reaction tetracycline linezolid Has receive investigational drug within past 30 day Women pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>